Author

Hallgeir Jonvik

National Hospital for Neurology and NeurosurgeryORCID 0000-0002-1306-8958Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Approach:statistical model· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Emmeline E. BrowniD· 2 shared Mie RizigiD· 2 shared Alan Michael PittmaniD· 1 shared Alexis BriceiD· 1 shared Andrew SingletoniD· 1 shared Chokri MhiriiD· 1 shared Cornelis BlauwendraatiD· 1 shared Donald G. GrossetiD· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetics

Emmeline E. BrownORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinsons disease

Emmeline E. Brown, Cornelis Blauwendraat, Joanne Trinh, Mie Rizig, Mike A. Nalls, Etienne Léveillé, Jennifer A. Ruskey, Hallgeir Jonvik, Manuela M. X. Tan, Sara Bandrés‐Ciga, Sharon Hassin‐Baer, Kathrin Brockmann, Jon Infante, EDUARDO S. TOLOSA, Mario Ezquerra, , Huw R. Morris

The paper examines DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson's disease, finding no significant effect of DNM3 on age at onset but a possible interaction between LRRK2 and VAMP4.

Neurobiology of Aging · Jul 13, 2020Peer-reviewedGenetics

Leucine Rich Repeat Kinase 2 (LRRK2) Gly2019Ser Mutation Is Absent In A Second Cohort Of Nigerian Africans With Parkinson Disease.

Njideka Ulunma Okubadejo, Mie Rizig, Oluwadamilola Omolara Ojo, Hallgeir Jonvik, Olajumoke Olufemi Oshinaike, Emmeline E. Brown, Henry Houlden

The paper confirms the absence of the LRRK2 p.G2019S mutation in a larger Nigerian cohort of Parkinson's disease patients and controls, supporting its origin after human dispersal from sub-Saharan Africa.

PLoS ONE · Dec 3, 2018Peer-reviewedGenetics